Loading...
Avant Brands Inc.
AVNT.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.69
CA$0.02(2.99%)
Avant Brands Inc. (AVNT.TO) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Avant Brands Inc. (AVNT.TO), featuring income statements, balance sheets, and cash flow data.
Revenue Growth
35.91%
↑ 35.91%
Operating Income Growth
-819.78%
↓ 819.78%
Net Income Growth
-344.85%
↓ 344.85%
Operating Cash Flow Growth
-90.64%
↓ 90.64%
Operating Margin
-33.49%
↓ 33.49%
Gross Margin
-5.90%
↓ 5.90%
Net Profit Margin
-57.04%
↓ 57.04%
ROE
-52.83%
↓ 52.83%
ROIC
-28.11%
↓ 28.11%
Avant Brands Inc. (AVNT.TO) Income Statement & Financial Overview
Review Avant Brands Inc. AVNT.TO income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $8.60M | $10.97M | $8.46M | $8.29M |
| Cost of Revenue | $7.02M | $12.73M | $7.46M | $10.11M |
| Gross Profit | $1.58M | -$1.75M | $1.003M | -$2.98M |
| Gross Profit Ratio | $0.18 | -$0.16 | $0.12 | -$0.36 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.89M | $1.75M | $2.62M | $2.76M |
| Operating Expenses | $2.35M | $2.38M | $3.52M | $3.23M |
| Total Costs & Expenses | $9.37M | $15.10M | $10.98M | $13.05M |
| Interest Income | $0.00 | -$55000.00 | $0.00 | $0.00 |
| Interest Expense | $151000.00 | $483000.00 | $279000.00 | $288000.00 |
| Depreciation & Amortization | $1.12M | $1.07M | $154000.00 | $3.21M |
| EBITDA | $350000.00 | -$13.55M | -$2.52M | -$1.54M |
| EBITDA Ratio | $0.04 | -$1.24 | -$0.30 | -$0.19 |
| Operating Income | -$769000.00 | -$4.13M | -$2.51M | -$4.76M |
| Operating Income Ratio | -$0.09 | -$0.38 | -$0.30 | -$0.57 |
| Other Income/Expenses (Net) | -$152000.00 | -$10.98M | -$431000.00 | $27000.00 |
| Income Before Tax | -$921000.00 | -$15.11M | -$2.94M | -$5.03M |
| Income Before Tax Ratio | -$0.11 | -$1.38 | -$0.35 | -$0.61 |
| Income Tax Expense | $0.00 | -$1.99M | $0.00 | -$1.29M |
| Net Income | -$921000.00 | -$13.13M | -$2.94M | -$3.73M |
| Net Income Ratio | -$0.11 | -$1.20 | -$0.35 | -$0.45 |
| EPS | -$0.09 | -$1.34 | -$0.28 | -$0.40 |
| Diluted EPS | -$0.09 | -$1.34 | -$0.28 | -$0.40 |
| Weighted Avg Shares Outstanding | $10.68M | $9.82M | $10.46M | $9.44M |
| Weighted Avg Shares Outstanding (Diluted) | $10.68M | $9.82M | $10.46M | $9.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan